GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » Gross Margin %

ANG Lifesciences India (BOM:540694) Gross Margin % : 37.59% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. ANG Lifesciences India's Gross Profit for the three months ended in Dec. 2023 was ₹70 Mil. ANG Lifesciences India's Revenue for the three months ended in Dec. 2023 was ₹185 Mil. Therefore, ANG Lifesciences India's Gross Margin % for the quarter that ended in Dec. 2023 was 37.59%.


The historical rank and industry rank for ANG Lifesciences India's Gross Margin % or its related term are showing as below:

BOM:540694' s Gross Margin % Range Over the Past 10 Years
Min: 25.6   Med: 29.61   Max: 35.62
Current: 27.67


During the past 11 years, the highest Gross Margin % of ANG Lifesciences India was 35.62%. The lowest was 25.60%. And the median was 29.61%.

BOM:540694's Gross Margin % is ranked worse than
81.03% of 986 companies
in the Drug Manufacturers industry
Industry Median: 47.02 vs BOM:540694: 27.67

ANG Lifesciences India had a gross margin of 37.59% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for ANG Lifesciences India was 2.90% per year.


ANG Lifesciences India Gross Margin % Historical Data

The historical data trend for ANG Lifesciences India's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India Gross Margin % Chart

ANG Lifesciences India Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.80 29.82 32.45 35.62 31.48

ANG Lifesciences India Quarterly Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.95 6.65 34.55 35.30 37.59

Competitive Comparison of ANG Lifesciences India's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANG Lifesciences India's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's Gross Margin % distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's Gross Margin % falls into.



ANG Lifesciences India Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

ANG Lifesciences India's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=691.9 / 2197.783
=(Revenue - Cost of Goods Sold) / Revenue
=(2197.783 - 1505.897) / 2197.783
=31.48 %

ANG Lifesciences India's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=69.7 / 185.455
=(Revenue - Cost of Goods Sold) / Revenue
=(185.455 - 115.745) / 185.455
=37.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


ANG Lifesciences India  (BOM:540694) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

ANG Lifesciences India had a gross margin of 37.59% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


ANG Lifesciences India Gross Margin % Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ANG Lifesciences India (BOM:540694) Business Description

Traded in Other Exchanges
N/A
Address
Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. Geographically, the company carries out sales within India, as well as outside India; generating the majority of revenue from the sales of injections within India.

ANG Lifesciences India (BOM:540694) Headlines

No Headlines